The RM-1-PSCA tumor growth rate in the pVAX1-PSCA-F2A-CTLA-4-vaccinated mice was lower than that in the mice treated with the control plasmid pVAX1 (Figure 4A). This evidence concerns the gene CTLA4 and neoplasm.